Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luke Gammon

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Oncotarget|March 24, 2018
Effects of Cetuximab and Erlotinib on the behaviour of cancer stem cells in head and neck squamous cell carcinomaMaria Fernanda Setúbal Destro Rodrigues, Luke Gammon, Muhammad M Rahman, et al.
Cancer Research|June 21, 2011
Cancer stem cells in squamous cell carcinoma switch between two distinct phenotypes that are preferentially migratory or proliferativeAdrian Biddle, Xiao Liang, Luke Gammon, et al.
Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology|August 30, 2014
Elevation in 5-FU-induced apoptosis in head and neck cancer stem cells by a combination of CDHP and GSK3β inhibitorsHideo Shigeishi, Adrian Biddle, Luke Gammon, et al.
Frontiers in Immunology|May 10, 2021
Oxidative Stress-Mediated YAP Dysregulation Contributes to the Pathogenesis of Pemphigus VulgarisYunying Huang, Hana Jedličková, Yang Cai, et al.
Elife|November 17, 2023
Disseminating cells in human oral tumours possess an EMT cancer stem cell marker profile that is predictive of metastasis in image-based machine learningGehad Youssef, Luke Gammon, Leah Ambler, et al.
Stem Cells (Dayton, Ohio)|May 8, 2013
Maintenance of stem cell self-renewal in head and neck cancers requires actions of GSK3β influenced by CD44 and RHAMMHideo Shigeishi, Adrian Biddle, Luke Gammon, et al.
Journal of Dermatological Science|January 23, 2009
Characterization of immortalized human epidermolysis bullosa simplex (KRT5) cell lines: trimethylamine N-oxide protects the keratin cytoskeleton against disruptive stress conditionJean Christopher Chamcheu, Elizabeth Pavez Lorié, Baki Akgul, et al.
Biotechniques|February 26, 2020
A cell-based assay for the detection of neutralizing antibodies against alemtuzumabLiaqat Ali, Gauri Saxena, Meleri Jones, et al.
The Journal of Investigative Dermatology|April 4, 2008
Potential of fibroblast cell therapy for recessive dystrophic epidermolysis bullosaTracy Wong, Luke Gammon, Lu Liu, et al.
BMC Biology|August 3, 2025
A CD24<sup>+</sup>CD271<sup>+</sup> melanoma cancer stem cell possesses hybrid characteristics of its single marker counterparts and promotes invasion and therapeutic resistanceOlivia Knowles, Patricio Doldan, Isabella Hillier-Richardson, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Oncotarget|March 24, 2018
Effects of Cetuximab and Erlotinib on the behaviour of cancer stem cells in head and neck squamous cell carcinomaMaria Fernanda Setúbal Destro Rodrigues, Luke Gammon, Muhammad M Rahman, et al.
Cancer Research|June 21, 2011
Cancer stem cells in squamous cell carcinoma switch between two distinct phenotypes that are preferentially migratory or proliferativeAdrian Biddle, Xiao Liang, Luke Gammon, et al.
Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology|August 30, 2014
Elevation in 5-FU-induced apoptosis in head and neck cancer stem cells by a combination of CDHP and GSK3β inhibitorsHideo Shigeishi, Adrian Biddle, Luke Gammon, et al.
Frontiers in Immunology|May 10, 2021
Oxidative Stress-Mediated YAP Dysregulation Contributes to the Pathogenesis of Pemphigus VulgarisYunying Huang, Hana Jedličková, Yang Cai, et al.
Elife|November 17, 2023
Disseminating cells in human oral tumours possess an EMT cancer stem cell marker profile that is predictive of metastasis in image-based machine learningGehad Youssef, Luke Gammon, Leah Ambler, et al.
Stem Cells (Dayton, Ohio)|May 8, 2013
Maintenance of stem cell self-renewal in head and neck cancers requires actions of GSK3β influenced by CD44 and RHAMMHideo Shigeishi, Adrian Biddle, Luke Gammon, et al.
Journal of Dermatological Science|January 23, 2009
Characterization of immortalized human epidermolysis bullosa simplex (KRT5) cell lines: trimethylamine N-oxide protects the keratin cytoskeleton against disruptive stress conditionJean Christopher Chamcheu, Elizabeth Pavez Lorié, Baki Akgul, et al.
Biotechniques|February 26, 2020
A cell-based assay for the detection of neutralizing antibodies against alemtuzumabLiaqat Ali, Gauri Saxena, Meleri Jones, et al.
The Journal of Investigative Dermatology|April 4, 2008
Potential of fibroblast cell therapy for recessive dystrophic epidermolysis bullosaTracy Wong, Luke Gammon, Lu Liu, et al.
BMC Biology|August 3, 2025
A CD24<sup>+</sup>CD271<sup>+</sup> melanoma cancer stem cell possesses hybrid characteristics of its single marker counterparts and promotes invasion and therapeutic resistanceOlivia Knowles, Patricio Doldan, Isabella Hillier-Richardson, et al.
Pageof 3